Leif Bergsagel, MD
Healthcare Professional Consultant
Division of Hematology/Oncology
Mayo Clinic Collaborative Research Building
East Shea Boulevard
Scottsdale, Arizona, United States
Leif Bergsagel completed his graduation in science and MD from University of Toronto. He did Internship and Residency in Sunnybrook Medical Centre, Toronto. Dr. Bergsagel mainly treats these conditions: amyloidosis, monoclonal gammopathy of undetermined significance, multiple myeloma, and Waldenstrom macroglobulinemia.
Dr. Bergsagel has been involved in the studies on molecular pathogenesis of multiple myeloma, a tumor of mature, isotype-switched plasma cells. It is a uniformly fatal malignancy that is frequently preceded by a common (1 percent of adults), benign preclinical phase known as monoclonal gammopathy of undetermined significance (MGUS). Dr. Bergsagel’s laboratory is focused on understanding the molecular events that lead to the development of MGUS and its progression to multiple myeloma.
The research of Dr. Bergsagel and his colleagues has identified important subtypes of multiple myeloma that respond differently to treatment, are associated with different survival rates and form the basis for a risk-adapted approach to therapy.
Representative Publications:
rareRelated
- Amyloid Planet: Perspectives on Amyloidosis and Protein Misfolding DisordersThe most widely used system is the Europ...
- The University of Kansas Health System – Center for TransplantationThe center for transplantation at The Un...
- Ajai Chari, MDDr. Chari is an Associate Professor of M...
- Charlotte HaffnerCharlotte Haffner is the first Vanderbil...
- Stanley Schrier, MDDr. Schrier is a practicing hematologist...
- Rebuilding the Immune SystemLosing one’s immune system is a seriou...
- Larry Anderson, MD, PhDLarry Anderson is Associate Professor ...